#pharmaceutical company

Collection of pharmaceutical company news, found 266 news.

Indonesia currently developing its own Red and White vaccine: Jokowi

President Joko Widodo (Jokowi) spoke of the government currently developing and working on two vaccines, specifically ...

Health protocols paramount as COVID-19 vaccine scheduled in early 2021

The Policy Committee for COVID-19 Handling and National Economic Recovery reminded that the Sinovac-Bio Farma COVID-19 ...

Prototype of COVID-19 vaccine enters initial stage of production

Research and Technology Minister Bambang Brodjonegoro confirmed that the COVID-19 prototype vaccine had currently ...

DENSO, Global Mobility Service to Support Delivery of COVID-19 Test Kits in Indonesia

DENSO Coporation and Global Mobility Service Inc. (GMS) announced today they will support the delivery of polymerase ...

Aptorum Group collaborates with Covar Pharmaceuticals to investigate at least 3 repurposed drug candidates (SACT-COV19) for coronavirus disease 2019 (COVID-19)

- Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of ...

Minister supports plan to substitute imported pharmaceutical products

Industry Minister Agus Gumiwang Kartasasmita has encouraged efforts to substitute imported pharmaceutical products with ...

Raw material being imported for masks from Europe

The Indonesian government is considering importing raw material for the production of masks from Europe since the stock ...

Takeda completes sale of select OTC and non-core assets to Acino

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its ...

Takeda agrees to divest select OTC and non-core assets in Latin America to Hypera Pharma for $825 million USD

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

Aptorum Group commences commercialization of dioscorea opposita bioactive nutraceutical tablets and signed sales distribution agreement in Hong Kong

- Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel ...

Aptorum Group announces significant progress of repurposed drug candidate, SACT-1 for neuroblastoma targeting IND submission in H2 2020

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group announces further positive data for its ALS-4 small molecule Anti-virulence (Non-bactericidal) drug candidate for the treatment of infections caused by Staphylococcus aureus and on track

- Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Indonesia signs Rp9.75 billion-worth deals at Vietnam Expo

Indonesian products clinched Rp9.75 billion in potential transactions at the Vietnam Expo 2019 held at Saigon ...

Takeda continues strategic divestitures with sale of select OTC and non-core assets to STADA for $660 million USD

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

Takeda agrees to divest select OTC and non-core assets to Acino for over $200 million USD

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...